Test

Click the title above for a link to open the Pharmaceutical Executive April 2024 issue in an interactive PDF format.

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.

Efforts to partner and collaborate within the life sciences industry—and externally with governments, regulators, and others—have taken on added weight in recent years.

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract Gen-Z.

Alvotech’s and Teva's Selarsdi (ustekinumab-aekn), the second FDA-approved biosimilar to Stelara, is indicated to treat patients aged 6 years and above with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy and for patients aged 6 years and above with active psoriatic arthritis.

BrandShield states that it has identified sites selling counterfeit versions of Wegovy and Ozempic, among other drugs.